Page 1 Nyrada Inc. Level 3, 828 Pacific Highway, Gordon NSW 2072 ARBN 625 401 818 18 August 2026 Sydney, Australia Appendix 4G and Corporate Governance Statement Nyrada Inc (ASX: NYR), a clinical-stage biotechnology company focused on developing Transient Receptor...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
Later from Nyrada
- Preliminary Final Report
- Annual Report for year ended 30 June 2026
- Nyrada Full Year Results FY2026
- Xolatryp Demonstrates Cardioprotection in Preclinical Study
- Application for quotation of securities - NYR
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada